Use of negative thyroid transcription factor (TTF-1) status to predict for negative epidermal growth factor receptor (EGFR) mutations (Mts) status with a high negative predictive value (NPV) in patients (pts) with adenocarcinomas (AC) of the lung.
N. Somaiah
Honoraria - Response Genetics
Research Funding - Response Genetics
E. Garrett-Mayer
No relevant relationships to disclose
X. Huang
Employment or Leadership Position - Response Genetics
A. E. Wahlquist
No relevant relationships to disclose
K. Danenberg
Employment or Leadership Position - Response Genetics
Stock Ownership - Response Genetics
G. R. Simon
Honoraria - Response Genetics
Research Funding - Response Genetics